The hospital will contact the woman via email with a booking appointment.
Women that are out of area can send an email to the Manager of the hospital they wish to birth at asking to be accepted as an out of area booking.
Gestational diabetes mellitus flowcharts
The flowchart for screening, diagnosing and referring of Gestational Diabetes Mellitus has been updated to reflect that screening for high risk women should ideally be after 13 weeks gestation.
Hyperemesis Gravidarum is the leading cause of hospitalisation during early pregnancy, and second to premature labour as the leading cause overall during pregnancy. HG usually extends beyond the first trimester and may resolve by 21 weeks; however, it can last the entire pregnancy.
Severe HG is often associated with:
loss of greater than 5 percent of pre-pregnancy body weight (usually over 10 percent),
dehydration,
nutritional deficiencies,
metabolic imbalances,
severe fatigue and debility,
depression/anxiety and trauma,
premature labour/delivery, and
adverse fetal complications.
Emerging evidence has found a genetic association predisposing women to HG and children born to mothers diagnosed with HG, are more predisposed to autism spectrum disorder, learning difficulty, depression, anxiety and processing disorders.
May is HG awareness month, NSW Health used the awareness day on Sunday 15 may to highlight awareness of HG on their Facebook page and launched a dedicated webpage to educate professionals and the public about HG.
The NSW Health Guideline Identification and Management of Nausea & Vomiting in Pregnancy and Hyperemesis Gravidarum is due to be published and will ensure clear management and treatment pathways. SESLHD aim to develop models of care that integrate hospital, community and primary care pathways to optimise treatment that suits the needs of the community and hospital service.
SESLHD project lead Joanna Pinder can be contacted with any questions regarding care of women with HG. Joanna Pinder can be contacted via email at joanna.pinder@health.nsw.gov.au
Maroubra Medicare Urgent Care Clinic (UCC) is now open The Maroubra Medicare Urgent Care Clinic (UCC) is now open, seven days a week, from 8.00am to 8.00pm. It was officially launched by member for Kingsford Smith, the hon Matt Thistlethwaite MP (pictured at the launch with CESPHN CEO Nathalie Hansen…
Media Release: Central and Eastern Sydney PHN releases Healthy Ageing Strategy to empower older people In response to the increasing longevity and rapid growth of the older population the Central and Eastern Sydney Primary Health Network (CESPHN) is proud to release its new Healthy Ageing Strategy 2023-2028. This comprehensive strategy…
Immunisation Weekly Update: Are your vaccines ready for summer? In the summer season, storms are more likely to occur, which can lead to power outages. Refer to the Cold Chain Toolkit to ensure all vaccination storage requirements are in place should an outage occur. Disposal of Zostavax® Zostavax® vaccine will…
Immunisation Weekly Update: COVID-19 XBB.1.5 vaccine onboarding The Australian Government has accepted the latest advice from ATAGI on the use of the new COVID-19 XBB 1.5 vaccine as part of the National COVID-19 Vaccine Program. All sites currently participating in the COVID-19 Vaccination Program will be onboarded for the three…
Immunisation Weekly Update: Increase in COVID-19 infection cases ATAGI notes a recent increase in COVID-19 cases since November 2023 across Australia and encourages all eligible people who have not yet had their recommended 2023 COVID-19 vaccine dose/s to receive them as soon as possible. A first 2023 dose is recommended…
Immunisation Weekly Update: Vaccination coverage in RACF Australian Immunisation Register (AIR) data suggests that only 36% of people aged 70+ living in the central and eastern Sydney PHN region are immunised against Pneumococcal diseases. Immunisation providers are reminded to check AIR immunisation history statements of patients going into Residential Aged…
Immunisation Weekly Update: Introduction of Shingrix® to the NIP From 1 November 2023, the shingles vaccine Shingrix® will replace Zostavax® on the National Immunisation Program (NIP) schedule for the prevention of shingles and post-herpetic neuralgia. It will be available for eligible people most at risk of complications from shingles. A…
NSW urged to prepare for heat wave Severe heatwave conditions are forecast in NSW in the coming days. Please read the NSW Health media release about taking steps to prevent heat-related illness. For further information about staying safe in a heatwave, visit Beat the heat and stay well during hot…